Survey on oral coloration when taking orally disintegrating tablets in patients with Parkinson's disease

Survey on oral coloration when taking orally disintegrating tablets in patients with Parkinson's disease - Survey on oral coloration when taking orally disintegrating tablets in patients with Parkinson's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038418

Enrollment

Registered

2019-11-20

Start date

2019-11-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with Parkinson's disease who are hospitalized or going to Showa University Hospital East Hospital 2) Patients who are over 20 years old when obtaining consent 3) Patients who can take internal medicine by themselves 4) Patients who have given written consent to participate in this study

Exclusion criteria

Exclusion criteria: 1) Patients judged to be ineligible at the discretion of the researcher

Design outcomes

Primary

Measure	Time frame
VAS score on the desire to take orally disintegrating tablets	—

Countries

Japan

Contacts

Public ContactNoriko HIDA

Showa university school of medicine

n.hida@med.showa-u.ac.jp03-3300-5254

Outcome results